Iron showdown: pills vs IV for anemia in late pregnancy
NCT ID NCT07485023
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two ways to treat anemia in pregnant women diagnosed after 34 weeks: taking iron pills daily or getting iron through a vein (IV). The goal is to see which approach raises hemoglobin levels better by the time of delivery. About 128 women will take part, and the results could help guide treatment choices for late-pregnancy anemia.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Iron (oral or intravenous)
- What this could lead to
- If it works, this could show that early IV iron is a better option for quickly raising hemoglobin in late pregnancy, potentially reducing the need for blood transfusions.
- What could go wrong
- This is a small, early-stage trial (128 participants) that has not yet started recruiting. Results may not apply to all pregnant women, and IV iron carries rare risks like allergic reactions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 128 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jul 2026
An estimate. Start dates often move.
- Expected to finish
-
Sep 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 50 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * • Women aged 18 years or older. * Singleton pregnancy. * Gestational age ≥34+0 weeks at the time of anemia diagnosis. * Hemoglobin \<11 g/dL measured as part of routine antenatal care. * Ongoing antenatal follow-up at Policlinico Umberto I. * Ability to understand study procedures and provide written informed consent. Exclusion Criteria: * • Known anemia not primarily due to iron deficiency. * Known hemoglobinopathies. * Severe anemia requiring immediate blood transfusion. * Previous severe hypersensitivity reaction to IV iron formulations. * Chronic hematologic disease. * Acute infection or inflammatory condition at enrollment. * Severe hepatic or renal impairment. * Any condition judged by the investigator to make participation unsafe.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anemia complicating pregnancy are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.